Google Chrome
Safari
Firefox
Edge
Sunriser® DPI
High Performance, High-Dose Capsule DPI.
Search
Article / Apr 01, 2007
Hovione Licenses Inhaler Technology to Sankyo & Biota
Drug Delivery Technology, April 2007
Press Clipping / May 11, 2026
Hovione and IDC announce new single-use capsule-based intranasal delivery device for dry powder formulations
OINDP - Orally inhaled and nasal drug products news, May 11, 2026
Filling
Fully-integrated Filling for your device needs.
Press Release / Apr 15, 2009
TwinCaps® in Phase III clinical trials for influenza
Hovione’s TwinCaps® inhaler in Phase III clinical trials for influenza
Press Clipping / May 07, 2026
Hovione, IDC Launch Intranasal Drug Delivery Platform
Contract Pharma, 7 May 2026
Devices
Hovione offers simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.
Press Release / Sep 11, 2013
Hovione: EPO grants a new inhaler patent
Article / Sep 24, 2024
Formulating Inhaled Medicines
Excipient and delivery device selection play crucial roles in the formulation of inhaled drugs.
Article / Sep 10, 2019
Inhalation Drug Delivery: The Impact of Particle Size Reduction
Pharmaceutical Technology, September 2, 2019